financetom
Business
financetom
/
Business
/
BRIEF-KKR To Acquire Healthium For Around $839 Million - Sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-KKR To Acquire Healthium For Around $839 Million - Sources
May 6, 2024 12:31 AM

May 6 (Reuters) - Healthium Medtech Ltd:

* KKR TO ACQUIRE HEALTHIUM FOR AROUND $839 MILLION - SOURCES

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
CrowdStrike Names Alex Ionescu as Chief Technology Innovation Officer
CrowdStrike Names Alex Ionescu as Chief Technology Innovation Officer
Apr 3, 2025
09:01 AM EDT, 04/03/2025 (MT Newswires) -- CrowdStrike ( CRWD ) said Thursday it has named Alex Ionescu, the company's founding chief architect and former vice president of endpoint engineering, as chief technology innovation officer. Ionescu is returning to the company after playing a role in building the company's sensor related to the Falcon platform and its overall architectural direction,...
Aldeyra Therapeutics Gets US FDA Letter for Resubmission of New Drug Application for Eye Disease Treatment - Shares Slump Pre-Bell
Aldeyra Therapeutics Gets US FDA Letter for Resubmission of New Drug Application for Eye Disease Treatment - Shares Slump Pre-Bell
Apr 3, 2025
08:59 AM EDT, 04/03/2025 (MT Newswires) -- Aldeyra Therapeutics ( ALDX ) said Thursday that it has received a complete response letter from the US Food and Drug Administration for the resubmission of its new drug application for its potential dry eye disease treatment, reproxalap. The company said that no manufacturing or safety issues with reproxalap were identified, but the...
What's Going On With Visa Stock?
What's Going On With Visa Stock?
Apr 3, 2025
Shares of Visa Inc ( V ) fell 3.4% to $334.42 Thursday morning following President Donald Trump's announcement of sweeping reciprocal tariffs, which economists warn could destabilize global trade and dampen consumer spending. The payment giant, which derives a significant portion of its revenue from cross-border transactions, saw its stock decline as investors weighed the impact of escalating trade tensions...
Copyright 2023-2026 - www.financetom.com All Rights Reserved